Market Cap
Abbott Laboratories
$191.43 Billion
USD as of Jan. 1, 2023
Company | Market Cap (USD) |
---|---|
![]() |
$495.37 B |
![]() |
$461.85 B |
![]() |
$347.61 B |
![]() |
$304.61 B |
![]() |
$287.63 B |
Abbott Laboratories is a multinational health care and medical devices company. Founded in 1888, Abbot manufactures medical devices including cardiovascular and neuromodulation devices, diagnostics products, branded generic medicines, and nutritional products for children and adults including Pedialyte, Similac, Ensure, Glucerna, ZonePerfect, FreeStyle Libre, i-STAT, and MitraClip.
Abbott Laboratories has the following listings and related stock indices.
Stock: NYSE: ABT
Stock: BCBA: ABT
Stock: BMV: ABT
Stock: Bovespa: ABTT34
Stock: BVS: ABTCL
Stock: FSX: ABL
Stock: XETR: ABL
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.